An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Vaccines

CYFENDUS

STN: 125761
Proper Name: Anthrax Vaccine Adsorbed, Adjuvanted
Tradename: CYFENDUS
Manufacturer: Emergent Product Development Gaithersburg Inc.
Indication:

For post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of age when administered in conjunction with recommended antibacterial drugs

Product Information

Package Insert - CYFENDUS
Patient Information - CYFENDUS
Demographic Subgroup Information – Anthrax Vaccine Adsorbed, Adjuvanted (CYFENDUS)
Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.

Supporting Documents

Top